AstraZeneca Shares Climb 7% After Strong Results and Savings Plan
AstraZeneca shares rose nearly 7% after a Q3 earnings beat and a $1.5B savings plan; cancer drugs powered growth.
Blackstone now expects Anthropic to get a junk credit rating after its IPO, reversing earlier hopes for investment-grade status.
The lender that has $9 billion riding on Anthropic has revised its outlook. Blackstone now believes the company behind Claude will receive a junk credit rating following its record IPO, according to a Thursday report from the Financial Times.
Previously, Blackstone had told investors the opposite. It had anticipated an investment-grade rating by the end of the year. That rating determines how affordably Anthropic can borrow for a spending plan estimated at over $800 billion.
A credit rating functions as a report card for borrowers. A BBB- rating is considered the passing mark. Anything below that threshold is classified as junk.
Numerous pension funds and insurers have restrictions on holding junk-rated debt. Fewer available lenders translates to higher interest costs.
Kroll Bond Rating Agency (KBRA) assigned Anthropic a BB+ in June, one notch below investment grade. Blackstone now anticipates a BB-range rating from the major agencies, based on their feedback, the Times reported.
$ANT – ANTHROPIC FACES JUNK CREDIT RATING RISK DESPITE PLANNED MEGA-IPO
— *Walter Bloomberg (@DeItaone) October 30, 2026
Blackstone has warned investors that Anthropic may receive a below-investment-grade credit rating following its IPO, reversing earlier expectations, according to the Financial Times.
The AI company is…
The answer lies within Project North Star, Anthropic's $63 billion chip financing. More than $42 billion of those loans are backed by a guarantee from Broadcom, an investment-grade chipmaker.
The remaining $18 billion depends solely on Anthropic. Blackstone funds took approximately $9 billion of that portion, at yields exceeding 10%.
Anthropic holds over $112 billion in cash. Investors expect the IPO to raise roughly $100 billion more. Its prospectus describes the compute plan as "bold but sane," per the FT.
SpaceX achieved investment-grade ratings from all three major agencies days after its June IPO. In September, agencies still viewed Anthropic as speculative-grade, even as Goldman Sachs and Morgan Stanley advocated for investment-grade status.
Fitch, Moody's, and S&P have not yet issued their verdicts. Their decisions after the Nasdaq debut, expected by late November, will determine what Anthropic pays to borrow for its expansion.
Share to
Disclaimer: this article comes from third-party media and is provided for reference only. It does not constitute investment advice. Crypto and other financial products carry significant price volatility risk, so please make your own decisions carefully.
AstraZeneca shares rose nearly 7% after a Q3 earnings beat and a $1.5B savings plan; cancer drugs powered growth.
After sharp selloffs in Intel and Amazon, investors look to next week's reports from Apple, Palantir and AMD for reassurance on growth.
Coinbase missed Q3 revenue estimates and users dropped; CEO Armstrong set up a share sale plan. The Binance hack also hit crypto stocks.
Insider sales of 227,580 MSTR shares preceded the resignation of Strategy CFO Andrew Kang, who cited personal reasons.